Abstract
RNA-protein interactions critically regulate gene expression and cellular processes, yet their comprehensive mapping remains challenging due to their structural diversity. We introduce PRIM-seq (protein-RNA interaction mapping by sequencing), a method for concurrent de novo identification of RNA-binding proteins and their associated RNAs. PRIM-seq generates unique chimeric DNA sequences by proximity ligation of RNAs with protein-linked DNA barcodes, which are subsequently decoded through sequencing. We apply PRIM-seq to two human cell lines and construct a human RNA-protein association network (HuRPA), encompassing >350,000 associations involving ~7,000 RNAs and ~11,000 proteins, including 2,610 proteins that each interact with at least 10 distinct RNAs. We experimentally validate the tumorigenesis-associated lincRNA LINC00339, the RNA with the highest number of protein associations in HuRPA, as a protein-associated RNA. We further validate the RNA-associating abilities of chromatin-conformation regulators SMC1A, SMC3 and RAD21, as well as the metabolic enzyme PHGDH. PRIM-seq enables systematic discovery and prioritization of RNA-binding proteins and their targets without gene- or protein-specific reagents.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
Data availability
All PRIM-seq sequencing data has been deposited in GEO (GSE270010)93. All RIP-seq sequencing data have been deposited in GEO (GSE270009)94. Source data are provided with this paper.
Code availability
PRIMseqTools and its source code and complete documentation are available at GitHub95. A web interface for downloading, searching and visualizing the HuRPA network is available at https://sysbiocomp.ucsd.edu/prim/.
References
Liu, S. et al. Classification and function of RNA-protein interactions. Wiley Interdiscip. Rev. RNA 11, e1601 (2020).
Li, W. et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498, 516–520 (2013).
Yang, F. et al. The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding CTCF and maintains H3K27me3 methylation. Genome Biol. 16, 52 (2015).
Yin, Y. et al. U1 snRNP regulates chromatin retention of noncoding RNAs. Nature 580, 147–150 (2020).
Hentze, M. W., Castello, A., Schwarzl, T. & Preiss, T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 19, 327–341 (2018).
Thelen, M. P. & Kye, M. J. The role of RNA binding proteins for local mRNA translation: implications in neurological disorders. Front. Mol. Biosci. 6, 161 (2019).
Li, W., Deng, X. & Chen, J. RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. Semin. Cancer Biol. 86, 664–677 (2022).
Pederson, T. A layperson encounter, on the ‘modified’ RNA world. Proc. Natl Acad. Sci. USA 118, e2110706118 (2021).
Chen, L. L. Towards higher-resolution and in vivo understanding of lncRNA biogenesis and function. Nat Methods 19, 1152–1155 (2022).
García-Mauriño, S. M. et al. RNA binding protein regulation and cross-talk in the control of AU-rich mRNA fate. Front. Mol. Biosci. 4, 71 (2017).
Sanchez de Groot, N. et al. RNA structure drives interaction with proteins. Nat. Commun. 10, 3246 (2019).
Russell, R. RNA misfolding and the action of chaperones. Front. Biosci. 13, 1–20 (2008).
Witten, J. T. & Ule, J. Understanding splicing regulation through RNA splicing maps. Trends Genet. 27, 89–97 (2011).
Quinones-Valdez, G. et al. Regulation of RNA editing by RNA-binding proteins in human cells. Commun. Biol. 2, 19 (2019).
Maziuk, B., Ballance, H. I. & Wolozin, B. Dysregulation of RNA binding protein aggregation in neurodegenerative disorders. Front. Mol. Neurosci. 10, 89 (2017).
Stanley, R. F. & Abdel-Wahab, O. Dysregulation and therapeutic targeting of RNA splicing in cancer. Nat. Cancer 3, 536–546 (2022).
Enguita, F. J. et al. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. Theranostics 12, 3946–3962 (2022).
Ramanathan, M., Porter, D. F. & Khavari, P. A. Methods to study RNA-protein interactions. Nat. Methods 16, 225–234 (2019).
Gräwe, C., Stelloo, S., van Hout, F. A. H. & Vermeulen, M. RNA-centric methods: toward the interactome of specific RNA transcripts. Trends Biotechnol. 39, 890–900 (2021).
Garcia-Moreno, M. et al. System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection. Mol. Cell 74, 196–211 (2019).
Huang, R., Han, M., Meng, L. & Chen, X. Transcriptome-wide discovery of coding and noncoding RNA-binding proteins. Proc. Natl Acad. Sci. USA 115, E3879–E3887 (2018).
Bao, X. et al. Capturing the interactome of newly transcribed RNA. Nat. Methods 15, 213–220 (2018).
McHugh, C. A. & Guttman, M. RAP-MS: a method to identify proteins that interact directly with a specific RNA molecule in cells. Methods Mol. Biol. 1649, 473–488 (2018).
Matia-González, A. M., Iadevaia, V. & Gerber, A. P. A versatile tandem RNA isolation procedure to capture in vivo formed mRNA-protein complexes. Methods 118–119, 93–100 (2017).
Zeng, F. et al. A protocol for PAIR: PNA-assisted identification of RNA binding proteins in living cells. Nat. Protoc. 1, 920–927 (2006).
Tsai, B. P., Wang, X., Huang, L. & Waterman, M. L. Quantitative profiling of in vivo-assembled RNA-protein complexes using a novel integrated proteomic approach. Mol. Cell Proteomics 10, M110.007385 (2011).
Ramanathan, M. et al. RNA-protein interaction detection in living cells. Nat. Methods 15, 207–212 (2018).
Tsue, A. F. et al. Oligonucleotide-mediated proximity-interactome mapping (O-MAP): a unified method for RNA-targeted microenvironment-mapping in situ. Nat. Methods 21, 2058–2071 (2024).
Qin, W., Cho, K. F., Cavanagh, P. E. & Ting, A. Y. Deciphering molecular interactions by proximity labeling. Nat. Methods 18, 133–143 (2021).
Weissinger, R., Heinold, L., Akram, S., Jansen, R. P. & Hermesh, O. RNA proximity labeling: a new detection tool for RNA-protein interactions. Molecules 26, 2270 (2021).
Zhang, Z. et al. Capturing RNA-protein interaction via CRUIS. Nucleic Acids Res. 48, e52 (2020).
Li, Y. et al. CBRPP: a new RNA-centric method to study RNA-protein interactions. RNA Biol. 18, 1608–1621 (2021).
Gilbert, C. & Svejstrup, J. Q. RNA immunoprecipitation for determining RNA-protein associations in vivo. Curr. Protoc. Mol. Biol. Chapter 27, Unit 27.4 (2006).
Hafner, M. et al. CLIP and complementary methods. Nat. Rev. Methods Primers 1, 20 (2021).
Hafner, M. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129–141 (2010).
König, J. et al. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat. Struct. Mol. Biol. 17, 909–915 (2010).
Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464–469 (2008).
Van Nostrand, E. L. et al. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat. Methods. 13, 508–514 (2016).
Nawaz, A. et al. Serine 970 of RNA helicase MOV10 is phosphorylated and controls unfolding activity and fate of mRNAs targeted for AGO2-mediated. silencing. J. Biol. Chem. 299, 104577 (2023).
Weyn-Vanhentenryck, S. M. et al. HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism. Cell Rep. 6, 1139–1152 (2014).
Zarnegar, B. J. et al. irCLIP platform for efficient characterization of protein-RNA interactions. Nat. Methods 13, 489–492 (2016).
Hinze, F. et al. Expanding the map of protein-RNA interaction sites via cell fusion followed by PAR-CLIP. RNA Biol. 15, 359–368 (2018).
Gu, J. et al. GoldCLIP: gel-omitted ligation-dependent CLIP. Genomics Proteomics Bioinformatics 16, 136–143 (2018).
Porter, D. F. et al. easyCLIP analysis of RNA-protein interactions incorporating absolute quantification. Nat. Commun. 12, 1569 (2021).
McMahon, A. C. et al. TRIBE: hijacking an RNA-editing enzyme to identify cell-specific targets of RNA-binding proteins. Cell 165, 742–753 (2016).
Rahman, R., Xu, W., Jin, H. & Rosbash, M. Identification of RNA-binding protein targets with HyperTRIBE. Nat. Protoc. 13, 1829–1849 (2018).
Seo, K. W. & Kleiner, R. E. Profiling dynamic RNA-protein interactions using small-molecule-induced RNA editing. Nat. Chem. Biol. 19, 1361–1371 (2023).
Johnson, K. L. et al. Revealing protein-protein interactions at the transcriptome scale by sequencing. Mol. Cell. 81, 4091–4103.e9 (2021).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat. Soc. Series B Stat. Methodol. 57, 289–300 (1995).
Gene Ontology Consortium & Aleksander, S. A. et al. The Gene Ontology knowledgebase in 2023. Genetics. 224, iyad031 (2023).
Protter, D. S. W. & Parker, R. Principles and properties of stress granules. Trends Cell Biol. 26, 668–679 (2016).
Caudron-Herger, M., Jansen, R. E., Wassmer, E. & Diederichs, S. RBP2GO: a comprehensive pan-species database on RNA-binding proteins, their interactions and functions. Nucleic Acids Res. 49, D425–D436 (2021).
Cook, K. B., Kazan, H., Zuberi, K., Morris, Q. & Hughes, T. R. RBPDB: a database of RNA-binding specificities. Nucleic Acids Res. 39, D301–D308 (2011).
Giudice, G., Sánchez-Cabo, F., Torroja, C. & Lara-Pezzi, E. ATtRACT-a database of RNA-binding proteins and associated motifs. Database 2016, baw035 (2016).
Ghosh P., Murugavel P. & Sowdhamini R. hRBPome: a central repository of all known human RNA-binding proteins. Preprint at bioRxiv http://biorxiv.org/lookup/doi/10.1101/269043 (2018).
Perez-Perri, J. I. et al. Discovery of RNA-binding proteins and characterization of their dynamic responses by enhanced RNA interactome capture. Nat. Commun. 9, 4408 (2018).
Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42, D92–D97 (2014).
Mullari, M., Lyon, D., Jensen, L. J. & Nielsen, M. L. Specifying RNA-binding regions in proteins by peptide cross-linking and affinity purification. J. Proteome Res. 16, 2762–2772 (2017).
Castello, A. et al. Comprehensive identification of RNA-binding domains in human cells. Mol. Cell. 63, 696–710 (2016).
Kang, J. et al. RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility. Nucleic Acids Res. 50, D326–D332 (2022).
Masuda, A. et al. CUGBP1 and MBNL1 preferentially bind to 3′ UTRs and facilitate mRNA decay. Sci. Rep. 2, 209 (2012).
Oberstrass, F. C. et al. Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science. 309, 2054–2057 (2005).
Barabási, A. L. Scale-free networks: a decade and beyond. Science 325, 412–413 (2009).
Van Nostrand, E. L. et al. Author correction: a large-scale binding and functional map of human RNA-binding proteins. Nature 589, E5 (2021).
Ye, H. et al. The SP1-induced long noncoding RNA, LINC00339, promotes tumorigenesis in colorectal cancer via the miR-378a-3p/MED19 axis. Onco. Targets Ther. 13, 11711–11724 (2020).
Yuan, Y., Haiying, G., Zhuo, L., Ying, L. & Xin, H. Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1. Biomed. Pharmacother. 105, 707–713 (2018).
Stelzer, G. et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinformatics 54, 1.30.1–1.30.33 (2016).
Zhang, W., Xie, M., Shu, M. D., Steitz, J. A. & DiMaio, D. A proximity-dependent assay for specific RNA-protein interactions in intact cells. RNA 22, 1785–1792 (2016).
Kattah, N. H., Kattah, M. G. & Utz, P. J. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol. Rev. 233, 126–145 (2010).
Reid, M. A., Dai, Z. & Locasale, J. W. The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat. Cell Biol. 19, 1298–1306 (2017).
Chen, X. et al. PHGDH expression increases with progression of Alzheimer’s disease pathology and symptoms. Cell Metab. 34, 651–653 (2022).
Liang, X. H. et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672–676 (1999).
Tran, S., Fairlie, W. D. & Lee, E. F. BECLIN1: protein structure, function and regulation. Cells 10, 1522 (2021).
Wortel, I. M. N., van der Meer, L. T., Kilberg, M. S. & van Leeuwen, F. N. Surviving stress: modulation of ATF4-mediated stress responses in normal and malignant cells. Trends Endocrinol. Metab. 28, 794–806 (2017).
Danzi, M. C. et al. The effect of Jun dimerization on neurite outgrowth and motif binding. Mol Cell Neurosci. 92, 114–127 (2018).
Zhu, H., Yu, H., Zhou, H., Zhu, W. & Wang, X. Elevated nuclear PHGDH synergistically functions with cMyc to reshape the immune microenvironment of liver cancer. Adv Sci. 10, e2205818 (2023).
Calandrelli, R. et al. Genome-wide analysis of the interplay between chromatin-associated RNA and 3D genome organization in human cells. Nat Commun. 14, 6519 (2023).
Soloviev, Z. et al. Structural mass spectrometry decodes domain interaction and dynamics of the full-length Human Histone Deacetylase 2. Biochim Biophys Acta Proteins Proteom. 1870, 140759 (2022).
Jankowsky, E. & Harris, M. E. Specificity and nonspecificity in RNA-protein interactions. Nat. Rev. Mol. Cell Biol. 16, 533–544 (2015).
Xiao, R. et al. Pervasive chromatin-RNA binding protein interactions enable RNA-based regulation of transcription. Cell 178, 107–121 (2019).
Dethoff, E. A. & Weeks, K. M. Effects of refolding on large-scale RNA structure. Biochemistry 58, 3069–3077 (2019).
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10–12 (2011).
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
O’Leary, N. A. et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 44, D733–D745 (2016).
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).
Thomas, P. D. et al. PANTHER: making genome-scale phylogenetics accessible to all. Protein Sci. 31, 8–22 (2022).
Bastian, M., Heymann, S. & Jacomy, M. Gephi: an open source software for exploring and manipulating networks. ICWSM 3, 361–362 (2009).
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell. 38, 576–589 (2010).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2013).
Zhijie Q., Shuanghong, X. & Kara J. Genome-wide mapping of RNA-protein associations via sequencing. Datasets. Gene Expression Omnibus https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270010 (2025).
Chen, J., Zhao, W., Qi, Z. & Wen, X. Identification of PHGDH protein-assocaited RNAs and their overlap with PRIM-seq derived RNAs through RIP-seq. Datasets. Gene Expression Omnibus https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270009 (2025).
Qi, Z. PRIMseqTools. Source code. GitHub https://github.com/Zhong-Lab-UCSD/PRIMseqTools.git (2025).
Acknowledgements
We thank UCSD IGM Genomics Center for support with sequencing. This work is supported by National Institutes of Health grants R01GM138852 (S.Z.), DP1DK126138 (S.Z.), UH3CA256960 (S.Z.) and R01HD107206 (S.Z.).
Author information
Authors and Affiliations
Contributions
Z.Q., S.X., K.J. and S.Z. designed the PRIM-seq technology. S.X. and K.J. generated the PRIM-seq libraries. Z.Q., X.W. and P.L. carried out the data analysis. S.X. carried out the RNA-PLA experiments. J.C. and W.Z. carried out RIP-seq and PHGDH perturbation experiments. Z.Q., S.X. and S.Z. took the lead in writing the manuscript. Z.Q., S.X., J.C., W.Z., P.L., J.L.C.R. and S.Z. contributed to the interpretation of the results, provided critical feedback and helped to shape the research, analysis and manuscript. J.C, W.Z. and K.J. contributed equally to this paper.
Corresponding author
Ethics declarations
Competing interests
S.Z. is a founder and shareholder of Genemo and Neurospan. The other authors declare no competing interests.
Peer review
Peer review information
Nature Biotechnology thanks David Tollervey and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 PRIM-seq’s experimental modules.
(a) SMART-display. (b-i) REILIS (Reverse transcription, Incubation, Ligation, and Sequencing).
Extended Data Fig. 2 PRIM-seq data processing.
(a) A cartoon showing the decoding of the protein-end and the RNA-end reads. As the sequencing reads from both ends are always from 5′ to 3′, the protein-end reads are always antisense sequences and the RNA-end reads are alway sense strand sequences. (b) The contingency table for testing the independence of a RNA (RNA A) and a protein (Protein B) from PRIM-seq data. Xij are the read counts. A Chi-square test is constructed from this contingency table for each pair of RNA and protein. (c) Flowchart of PRIMseqTools for processing PRIM-seq data. Adaptor sequences were trimmed (Adaptor trimming) and low-quality reads were removed (Quality filtering). The resulting read pairs were mapped to Refseq genes (Mapping). The read pairs with the two ends mapped to two different genes are retained (Identification of chimeric read pairs) and deduplicated. Non-duplicated chimeric read pairs with one end mapped to the sense strand of a gene and the other end mapped to the antisense strand of a protein-coding gene (RNA/protein end assignment) were used as the input for the Chi-square test (Statistical test).
Extended Data Fig. 3 Comparison of PRIM-seq and eCLIP data.
(a) Binding profiles of RPS3, FUS, SRSF1, and TAF15 on the TARDBP RNA comparing PRIM-seq (red tracks), eCLIP (green tracks), and eCLIP peaks called with Size‐matched Input (SMInput) controls (green bars beneath eCLIP tracks). Five binding sites shared by all four RBPs are consistently detected in both methods. Arrows mark notable site-specific differences: (1) a site bound by RPS3, FUS, and SRSF1 (but not TAF15); (2) a site bound by RPS3, FUS, and TAF15 (but not SRSF1); and (3) a site bound exclusively by FUS. Conversely, eCLIP identified a binding site for RPS3 not detected by PRIM-seq (Arrow 4). (b) Similar analysis on SNRPD3 RNA, where both PRIM-seq (red) and eCLIP (green) consistently identify multiple shared binding sites.
Extended Data Fig. 4 Gene Ontology analysis.
(a, d, f) The number of genes (x axis) in each GO term (dot) is plotted against the significance level (y axis) of this term in the HuRPA proteins. To avoid very general GO terms, we restricted our analysis to Biological Process (BP) terms with no more than 1,000 genes per term (a), and Cellular Component (CC) and Molecular Function (MF) terms with no more than 100 genes per term (d, f). Additionally, we annotated the most notable BP, CC, and MF terms with no more than 1,100, 110, and 110 genes, respectively (a, d, f). (b, e, g) The numbers of RNA-protein associations (RPAs), RNAs, and proteins in the HuRPA subnetworks associated with the most notable GO terms: ‘RNA processing’ (b), ‘cytoplasmic stress granule’ (e), and ‘translation factor activity, RNA binding’ (g). (c) Distribution of ‘RNA processing’ associated HuRPA proteins across different protein classes.
Extended Data Fig. 5 PTBP1-Associated RNAs.
(a) Distribution of PTBP1 target RNAs identified by PRIM-seq, highlighting the subset that overlaps with entries in the RNAInter database (pink) versus novel targets (green). (b) Motif frequency (y-axis) and statistical enrichment (x-axis, –log[p-value]) for each of the two de novo motifs uncovered by PRIM-seq. (c, d) An example depicting the ‘CUCUCUCUGG’ motif (red block) within a PRIM-seq peak (pink track). (e) Alignment of the top de novo motif (top) with the known PTBP1 motif (bottom), underscoring their strong similarity.
Extended Data Fig. 6 RNA-PLA analysis of RNA-protein pairs involving LINC00339 noncoding RNA.
(a–c) Representative images of the tests (protein name + LINC00039) (a), antibody-only controls (protein name + none) (b), other negative controls including no-probe-no-antibody control (none + none), RNA probe-only control (none + LINC00339), and four RNA-protein pairs not included in HuRPA (GFP + LINC0039, CD40 + LINC0039, CD32 + LINC0039, LTBR + LINC0039 (c). Quantification is provided in Fig. 3k. Blue: DAPI staining. Red: RNA-PLA signal. Scale bar = 20 μm. (d) ROC curve plotting the true positive rate (TPR, y-axis) against the false positive rate (FPR, x-axis), using HuRPA as the reference dataset and RNA-PLA as the test dataset, while varying the threshold applied to RNA-PLA signals.
Extended Data Fig. 7 Comparison between RNA Immunoprecipitation Sequencing (RIP-seq) and PRIM-seq data.
(a) Confusion matrix of all human RNA genes categorized according to their identification as SMC1A targets by PRIM-seq (rows) and RIP-seq (columns). (b) Chi-square test results derived from the confusion matrix in (a). (c–f) ROC curves evaluating PRIM-seq data against RIP-seq results for SMC1A, SMC3, RAD21, and HDAC2. RIP-seq-identified targets serve as the reference sets, and varying thresholds on PRIM-seq read counts are applied to define PRIM-seq-identified targets. (g–j) Expanded views of the ROC curves in (c–f), highlighting lower values on the x-axis. (k) Confusion matrix based solely on PRIM-seq reads within the HuRPA network, categorizing reads according to whether the protein-end maps to SMC1A (rows) and whether the RNA-end corresponds to SMC1A RIP-seq–identified target RNAs (columns). (l) Chi-square test results from the confusion matrix shown in (k). (m) Chi-square test results from a restricted version of the confusion matrix in (k), using only PRIM-seq reads involving SMC1A, SMC3, RAD21, and HDAC2 and their respective RIP-seq–identified target RNAs.
Extended Data Fig. 8 RIP-seq and RNA-PLA analysis of PHGDH.
(a) Categorization of PHGDH-associated RNAs in HuRPA by RNA classes. (b) The average RPM (reads per million, y axis) of each RNA gene (dot) in PHGDH RIP-seq vs. the enrichment level (-log10(adjusted p-value), x axis) of PHGDH as compared to IgG. Purple and red dots: RIP-seq identified PHGDH-associated RNAs. Red dots: PHGDH-associated RNAs identified by both RIP-seq and HuRPA. (c) Comparison of PHGDH-associated RNAs in HuRPA and detected by RIP-seq. Odds ratio (y axis) is greater than 1, indicating a strong overlap. Error bar: 95% confidence interval. As the threshold for calling PHGDH-associated RNAs from RIP-seq (x axis) increases, the odds ratio also increases, indicating a stronger overlap. (d) Among the PHGDH-associated RNAs in HuRPA, the RNA-end reads (y axis) of the RNAs detected (blue) by PHGDH RIP-seq are more than the RNAs not detected by PHGDH RIP-seq (orange). (e–h) Representative RNA-PLA images of the PHGDH protein and ATF4 mRNA (e), RNA-probe-only control (f), antibody-only control (g), and no-antibody-no-RNA-probe control (h). Scale bar = 20 μm.
Extended Data Fig. 9 Cellular responses to PHGDH knockdown in HEK293T cells.
Immunofluorescence staining and quantification of autophagosome (a, b), BrdU (c, d), and activated Caspase-3 (aCaspase3) (e,f) in scramble siRNA (Control) and PHGDH-targeting siRNAs (si-1, si-2) treated HEK293T cells. P-values are derived from two-sided t-tests. Error bar: SEM. n: number of replicates. Scale bars = 100 μm.
Extended Data Fig. 10 Cellular responses to PHGDH knockdown in mouse neural stem cells (mNSCs).
P-values are derived from two-sided t-tests. Error bar: SEM. n: number of replicates. Scale bars = 20 μm. (a) PHGDH RNA levels in scramble siRNA (Control) and PHGDH-targeting siRNAs (si-1, si-2) treated mNSCs. (b–g) Immunofluorescence staining and quantification of autophagosome (b, c), BrdU (d, e), and activated Caspase-3 (aCaspase3) (f, g) in scramble siRNA (Control) and PHGDH-targeting siRNAs (si-1, si-2) treated mNSCs. (h–j) Cell morphology analysis. Immunofluorescence staining of Nestin (h), normalized average dendrite length (i), and the number of dendrite intersections (y axis) as a function of distance from the soma (x axis) (j) in scramble siRNA (Control) and PHGDH-targeting siRNAs (si-1, si-2) treated mNSCs. Scale bars = 100 μm.
Supplementary information
Supplementary Information
The Supplementary Information file contains Supplementary Figs. 1–9 and Tables 1–7.
Source data
Source Data Fig. 5
The Source Data file contains all the uncropped blots for the main Fig. 5f,j,l,n,r,t.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Qi, Z., Xue, S., Chen, J. et al. Genome-wide mapping of RNA-protein associations through sequencing. Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02780-z
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41587-025-02780-z


